Calcium
phosphate cements (CPCs) have been widely used for the
study of bone regeneration because of their excellent physical and
chemical properties, but poor biocompatibility and lack of osteoinductivity
limit potential clinical applications. To overcome these limitations,
and based on our previous research, CPC scaffolds were prepared with
CPC as the principal material and polyethylene glycol (PEG) as a porogen
to introduce interconnected macropores. Using a bespoke electrospinning
auxiliary receiver, silk fibroin (SF)/poly(lactide-co-glycolide) (PLGA) coaxial nanofibers containing dexamethasone (DXM)
and recombinant human bone morphogenetic protein-2 (rhBMP2) were fabricated
which were coated on the surface of the CPC. By comparing the surface
morphology by SEM, hydrophilicity, results of FTIR spectroscopy, and
mechanical properties of the composite materials fabricated using
different electrospinning times (20, 40, 60 min), the CPC surface
constructed by electrospinning for 40 min was found to exhibit the
most appropriate physical and chemical properties. Therefore, composite
materials were built for further study by electrospinning for 40 min.
The osteogenic capacity of the SF/PLGA/CPC, SF-DXM/PLGA/CPC, and SF-DXM/PLGA-rhBMP2/CPC
scaffolds was evaluated by in vitro cell culture with rat bone marrow
mesenchymal stem cells (BMSCs) and using a rat cranial defect repair
model. ALP activity, calcium deposition levels, upregulation of osteogenic
genes, and bone regeneration in skull defects in rats with SF-DXM/PLGA-rhBMP2/CPC
implants were significantly higher than in rats implanted with the
other scaffolds. These results suggest that drug-loaded coaxial nanofiber
coatings prepared on a CPC surface can continuously and effectively
release bioactive drugs and further stimulate osteogenesis. Therefore,
the SF-DXM/PLGA-rhBMP2/CPC scaffolds prepared in this study demonstrated
the most significant potential for the treatment of bone defects.